PeopleBio, Inc. (KOSDAQ:304840)
South Korea
· Delayed Price · Currency is KRW 2,570.00
-20.00 (-0.77%)
At close: Jun 5, 2025, 3:30 PM KST
PeopleBio Revenue
PeopleBio had revenue of 779.55M KRW in the quarter ending March 31, 2025, with 4.71% growth. This brings the company's revenue in the last twelve months to 3.77B, down -9.23% year-over-year. In the year 2024, PeopleBio had annual revenue of 3.73B, down -16.20%.
Revenue (ttm)
3.77B
Revenue Growth
-9.23%
P/S Ratio
14.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
53.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.73B | -721.35M | -16.20% |
| Dec 31, 2023 | 4.45B | 8.02M | 0.18% |
| Dec 31, 2022 | 4.44B | 3.87B | 670.22% |
| Dec 31, 2021 | 577.08M | 69.23M | 13.63% |
| Dec 31, 2020 | 507.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| KB Financial Group | 14.93T |